Associations between Prediagnostic Circulating Bilirubin Levels and Risk of Gastrointestinal Cancers in the UK Biobank

SIMPLE SUMMARY: Evidence from experimental studies suggests that bilirubin, a metabolic by-product of hemoglobin breakdown, has anticancer activity and may, therefore, reduce the risk of gastrointestinal (GI) cancers. We conducted a prospective study among 440,948 participants in the UK Biobank and...

Descripción completa

Detalles Bibliográficos
Autores principales: Seyed Khoei, Nazlisadat, Wagner, Karl-Heinz, Carreras-Torres, Robert, Gunter, Marc J., Murphy, Neil, Freisling, Heinz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198711/
https://www.ncbi.nlm.nih.gov/pubmed/34206031
http://dx.doi.org/10.3390/cancers13112749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198711/
https://www.ncbi.nlm.nih.gov/pubmed/34206031
http://dx.doi.org/10.3390/cancers13112749

Ejemplares similares